Cargando…
Low EIF2B5 expression predicts poor prognosis in ovarian cancer
Ovarian cancer has the highest mortality among gynecological cancers. Although ovarian cancer usually responds well to chemotherapy, most patients still have a poor prognosis. EIF2B5 is a crucial molecule in posttranscriptional modifications involved in tumor progression, and here we investigated th...
Autores principales: | Hou, Lin, Jiao, Yan, Li, Yanqing, Luo, Zhangping, Zhang, Xueying, Pan, Guoqiang, Zhao, Yuechen, Yang, Zhaoying, He, Miao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004721/ https://www.ncbi.nlm.nih.gov/pubmed/32000373 http://dx.doi.org/10.1097/MD.0000000000018666 |
Ejemplares similares
-
Over-expression of CXCL2 is associated with poor prognosis in patients with ovarian cancer
por: Zhang, Fenghua, et al.
Publicado: (2021) -
Low FOXJ2 expression is associated with unfavorable postoperative prognosis of patients with epithelial ovarian cancer
por: Li, Yong, et al.
Publicado: (2021) -
High expression of PYK2 is associated with poor prognosis and cancer progression in early-stage cervical carcinoma
por: Zhang, Can, et al.
Publicado: (2022) -
Comprehensive analysis of the expression and prognosis for S100 in human ovarian cancer: A STROBE study
por: Xu, Hong-Yu, et al.
Publicado: (2020) -
Prenatal and postnatal diagnosis of congenital hymen prolapse: A case report
por: Zhang, Maochun, et al.
Publicado: (2023)